-
Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)
20 Feb 2025 22:50 GMT
… Drug Administration (FDA) is alerting the public that results from a clinical trial … about your medical treatment.
Lorcaserin is a prescription medicine approved by FDA in 2012 … XR).
When approving lorcaserin, we required the drug manufacturer, Eisai Inc …
-
FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market
20 Feb 2025 19:46 GMT
… (CAMELLIA-TIMI 61) clinical trial. It was a randomized … , multicenter, parallel group trial conducted between January 2014 and … trial, 462 (7.7 percent) patients treated with lorcaserin … treatment, but the imbalance increased with longer duration on lorcaserin.
-
Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight
08 Apr 2025 17:00 GMT
… Pharmaceuticals. Through this transaction, Immedica acquires Marinus' FDA-approved seizure medication … of the obesity drug lorcaserin in Dravet syndrome … clinical trials, visit @ Developmental and Epileptic Encephalopathies Treatment Drugs Developmental …
-
Developmental And Epileptic Encephalopathies Market To Observe Stunning Growth During The Study Period (2020–2034) | Delveinsight
08 Apr 2025 17:21 GMT
… Pharmaceuticals . Through this transaction, Immedica acquires Marinus' FDA-approved seizure medication … of the obesity drug lorcaserin in Dravet syndrome … clinical trials, visit @ Developmental and Epileptic Encephalopathies Treatment Drugs Developmental …
-
Eisai Closes Door on Lorcaserin Program for Dravet Syndrome
02 Dec 2024 21:25 GMT
… discontinued 2 clinical trials for lorcaserin in Dravet syndrome … lorcaserin as an effective antiseizure treatment after other medications failed.
Issues with the trial … FDA-approved weight-loss drug. In February 2020, Eisai voluntarily withdrew the medication …
-
Eisai terminates Phase 3 trial of Dravet drug lorcaserin
17 Nov 2024 18:21 GMT
-
Eisai terminates Phase 3 trial of Dravet drug lorcaserin
17 Nov 2024 10:44 GMT
-
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
16 Oct 2024 13:20 GMT
… biotechnology company focused on developing novel drugs for the targeted treatment … Food and Drug Administration (FDA)- approved … pharmaceutical companies engaged in drug research and clinical trials, as well as medical … tests. Compared to Lorcaserin, BMB-101 …
-
A Randomized Controlled Trial of Lorcaserin in Cocaine Use Disorder
07 Oct 2024 19:17 GMT
… US Food and Drug Administration-approved medications for the treatment of CUD, and … , placebo-controlled trial of lorcaserin in cocaine use disorder. Drug Alcohol Depend. 2024 … with lorcaserin – The FDA’s review of the CAMELLIA-TIMI 61 trial. N …
-
Phentermine and other psychotropic drugs prescribed as ‘diet pills’
07 Oct 2024 05:43 GMT
… , about 402,000 pills of lorcaserin-based psychotropic drugs, which were approved in … U.S. Food and Drug Administration's (FDA) decision to stop … .
“Diet pills with ingredients, such as phentermine and phendimetrazine, are medical narcotics …
About
© 1995-2025